Journal article
The role of oral methotrexate as a steroid sparing agent in refractory eosinophilic asthma.
- Abstract:
-
The use of oral methotrexate for refractory eosinophilic asthma in a tertiary asthma referral centre, Glenfield Hospital, Leicester, was evaluated between January 2006 and December 2014. The patients ( n = 61) were carefully phenotyped at baseline with markers of airway inflammation. In addition, a structured oral methotrexate proforma was utilized to evaluate response to therapy and adverse events. Oral steroid withdrawal was attempted 3 months after commencing treatment. Several outcomes we...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Authors
Funding
National Institute for Health Research
More from this funder
Bibliographic Details
- Publisher:
- SAGE Publications Publisher's website
- Journal:
- Chronic Respiratory Disease Journal website
- Publication date:
- 2017-06-01
- Acceptance date:
- 2017-03-21
- DOI:
- ISSN:
-
1479-9731
- Source identifiers:
-
700939
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
pubs:700939
- UUID:
-
uuid:54520e33-ab20-49e9-89a6-2de5ebd3f5f1
- Local pid:
- pubs:700939
- Deposit date:
- 2017-07-13
Terms of use
- Copyright holder:
- Pavord et al
- Copyright date:
- 2017
- Notes:
- © The Author(s) 2017. This article is distributed under the terms of the Creative Commons Attribution-Non Commercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
If you are the owner of this record, you can report an update to it here: Report update to this record